Routine diagnostic procedures of myelodysplastic syndromes: value of a structural blood cell parameter (NEUT‐X) determined by the Sysmex XE‐2100TM
暂无分享,去创建一个
F. Ajchenbaum‐Cymbalista | R. Letestu | P. Fenaux | F. Baran-Marszak | V. Eclache | G. Le Roux | A. Vlad | C. Malanquin | Jean-Francois Collon | M. Gantier | F. Schillinger | Julie Peltier | B. Savin
[1] B. Bain,et al. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts , 2008, Haematologica.
[2] F. Ajchenbaum‐Cymbalista,et al. Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring , 2007, Leukemia & lymphoma.
[3] P. Fenaux,et al. Treatment of the 5q- syndrome. , 2006, Hematology. American Society of Hematology. Education Program.
[4] G. Schiller,et al. Myelodysplasic syndromes: a comprehensive review. , 2005, Blood reviews.
[5] P. Fenaux,et al. Supportive care including growth factors in myelodysplastic syndromes. , 2004, Reviews in clinical and experimental hematology.
[6] J. Bayle,et al. Evaluation of the Sysmex Xe‐2100® hematology analyzer in hospital use , 2003, Journal of clinical laboratory analysis.
[7] H. Diem,et al. Performance of the XE-2100 leucocyte differential. , 2002, Clinical and laboratory haematology.
[8] I. Schwarzinger,et al. The new hematology analyzer Sysmex XE-2100: performance evaluation of a novel white blood cell differential technology. , 2001, Archives of pathology & laboratory medicine.
[9] J. Staves,et al. New quantitative parameters on a recently introduced automated blood cell counter--the XE 2100. , 2000, Clinical and laboratory haematology.